Ann: Quarterly Results and Investor Conference Call Notification, page-28

Unfortunately I won't be able to attend due to a client meeting, however I wonder if someone would be willing to ask if TK and BOD if they have received shareholder feedback (both large and retail) and been able to establish a broad based insight into shareholder appetite for the 11.5c Pfizer offer.

or words to that effect...

Don't expect anything other than Floyd Mayweather style ducking and weaving, but still worth a throw at the stumps.